A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants. (2012)

First Author: Odutola AA

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2012.06.054

PubMed Identifier: 22749600

Publication URI: http://europepmc.org/abstract/MED/22749600

Type: Journal Article/Review

Volume: 30

Parent Publication: Vaccine

Issue: 38

ISSN: 0264-410X